| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2012: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2011: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2010: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
|---|
| Research Abstract |
Due to the lack of effective chemotherapy, severe cryptosporidiosis especially seen in immune-compromised host is often fetal. To explore drug seeds for the opportunistic infection, a screening method of the drug effect against Cryptosporidiumparvum in a cell culture model was successfully developed. Using the assessment procedure, anti-cryptosporidal efficacy was confirmed in a part of adenosine analogues, including anti-cancer drugs used in clinical sites.
|
